American Society of Hypertension, inc.
2014 annual scientific meeting and exposition
ASH 2014
Letter from the President and Program Committee Chair Dear Colleague, On behalf of the Board of Directors of the American Society of Hypertension, Inc. (ASH), we are pleased to welcome you and cordially invite you to join us at the ASH Twenty-Ninth Annual Scientific Meeting and Exposition. The meeting will be held at the New York Hilton, May 16 – 20, 2014. The 2014 Annual Scientific meeting topics are organized around two (2) concurrent themes: Clinical Science and Clinical Practice. The Scientific Sessions feature several innovative components designed to enhance the translation of basic and applied research into eΩective hypertension prevention and treatment strategies. • Hypertension Highlights 2014 – Saturday, May 17, 2014 Hypertension Highlights is a full-day program dedicated to educating clinicians and scientists about some of the most interesting, controversial and evolving topics in the field. The program will include state-of-the-art presentations on Cholesterol Disorders and Management, Cardiovascular Impact of Type 2 Diabetes and Vasoactive Drug Development. It is an ideal update for Hypertension Specialists and those wishing to become specialists in the field. • Plenary Session I – Sunday, May 18, 2014 The Keynote speaker for the opening session will be Murray D. Esler, MBBS, PhD, Associate Director, Cardiovascular Neurosciences Division, Baker IDI Heart and Diabetes Institute, Melbourne, Australia. Dr. Esler will speak on “Sympathetic Nervous System and Hypertension.” Following Dr. Esler’s lecture will be Jan A. Staessen, MD, PhD, Professor of Medicine, Head, Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, Leuven, Belgium presenting a lecture on “Current Evidence and Perspectives on Renal Denervation in Hypertension and Related Disorders. Roxana Mehran, MD, Professor of Medicine and Health Policy, Director of Interventional Cardiovascular Research and Clinical Trials at the Zena and Michael A. Weiner Cardiovascular Institute at Mount Sinai School of Medicine, New York, New York, will then present a lecture entitled “Evaluation of Clinical Outcomes Following Peripheral Arterial Interventions: What is Needed for Renal Denervation Studies Long-term?" Ravij Agarwal, MD, FASH, Professor of Medicine, Division of Nephrology, Indiana University School of Medicine, Indianapolis, Indiana will address the topic of “Resistant Hypertension, Salt, and Successful Drug Therapy.” • Plenary Session II – Monday, May 18, 2014 The ASH Distinguished Scientist Award, Young Scholar Award and Marvin Moser Clinical Hypertension Award will be presented in Plenary Session II – the ASH Awards Session.
• Hypertension for the Primary Care Clinician – Friday, May 16 and Saturday May 17, 2014 This program will address commonplace questions that face clinicians in day-to-day care of hypertension including Blood Pressure Measurement, Special Populations and Resistant Hypertension. • Young Investigator-in-Training Abstract Competition – Sunday, May 18, 2014 Trainees submitting the highest ranking abstracts to the meeting will present their work orally in a special session and compete for cash prizes. This highlighted session is consistent with ASH’s goal to foster and facilitate the training of young and new investigators in hypertension. • Debates – Monday, May 18, 2014 This year there are several debates on controversial topics of relevance to Hypertension Specialists. • Joint Society Sessions Educational sessions resulting from the partnership with other societies, both national and international (including the AHA, ACC, ASN, ESH, PCNA and ISHIB [see below]), focused on the topic of hypertension and cardiovascular disease will enhance and broaden the scope of the ASH 2014 Meeting. • Joint Meetings with ISHIB Once again this year, ASH and the International Society on Hypertension in Blacks (ISHIB) will convene our annual conferences with the ISHIB meeting taking place immediately prior to the ASH 2014 Annual Scientific Meeting. The collaboration will benefit both societies in supporting our similar goals of improving the treatment of hypertension and advancing knowledge related to the disease; aΩording sponsors and attendees the convenience of taking in two meetings while only arranging travel to a single location. • Sponsored Satellite Symposia and Exhibits The Society will also sponsor industry-supported Satellite Symposia which will introduce novel approaches to antihypertensive and device therapies. The ASH Hypertension Resource Pavilion will host many informative scientific, technical, periodical and book exhibits designed to support you in your mission of providing the latest in care for your hypertensive patients. We look forward to seeing you in New York. Sincerely,
William B. White, MD, FASH Domenic A. Sica, MD, FASH ASH President Program Committee Chair and President-Elect
William B. White, MD, FASH
Domenic A. Sica, MD, FASH